Rubius Therapeutics Inc (NASDAQ:RUBY)

8.92
Delayed Data
As of Jan 17
 -0.92 / -9.35%
Today’s Change
6.96
Today|||52-Week Range
20.04
-6.11%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 19.00, with a high estimate of 40.00 and a low estimate of 3.00. The median estimate represents a +113.00% increase from the last price of 8.92.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Rubius Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.64
Sales
$0.00
Reporting Date
Mar 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.47%
 
 
 
 
 
 
Growthannually 4.85%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.